Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

316.27

-0.56 (-0.18%)

At close: Nov 12, 2026, 4:00 PM EST

317.00

+0.73 (0.23%)

After-hours: Nov 12, 2026, 7:59 PM EST

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,326	3,721	2,025	1,245	1,128	2,581
Market Cap Growth	53.58%	83.80%	62.59%	10.35%	-56.28%	61.40%
Enterprise Value	7,033	3,508	1,812	1,061	1,121	2,589
Last Close Price	316.27	189.07	107.15	71.42	66.80	99.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	132.25	29.90	-	23.88	-	45.18
Forward PE	45.16	35.20	53.58	35.07	298.37	298.37
PS Ratio	24.92	13.88	12.11	9.48	5.75	10.69
PB Ratio	6.58	3.66	2.44	1.78	1.89	3.14
P/TBV Ratio	14.00	5.39	4.42	4.18	8.11	7.85
P/FCF Ratio	69.81	76.09	21.26	27.04	8.99	36.86
P/OCF Ratio	69.50	75.39	20.86	25.12	8.19	32.76
PEG Ratio	1.85	2.42	3.57	2.34	23.42	18.19

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	27.71	13.08	10.84	8.08	5.71	10.72
EV/EBITDA Ratio	98.40	43.32	31.11	22.90	27.11	22.09
EV/EBIT Ratio	192.65	74.32	78.73	108.04	369.11	39.07
EV/FCF Ratio	77.60	71.72	19.03	23.04	8.93	36.96

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.20	0.44	0.01	0.01	0.15	0.40
Debt / EBITDA Ratio	16.01	5.52	0.12	0.13	2.09	2.74
Debt / FCF Ratio	12.74	9.23	0.08	0.13	0.70	4.63
Net Debt / Equity Ratio	0.74	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	9.89	-3.48	-4.27	-3.54	-3.00	-0.14
Net Debt / FCF Ratio	7.80	-5.77	-2.61	-3.56	-0.99	-0.24
Asset Turnover	0.14	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	2.67	8.24	1.71	1.88	4.38	3.50
Quick Ratio	1.16	21.83	8.32	12.49	2.50	10.39
Current Ratio	1.22	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	5.38%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	1.23%	2.36%	1.66%	0.79%	0.18%	3.11%
Return on Invested Capital (ROIC)	2.96%	5.61%	-6.59%	1.64%	-0.07%	8.50%
Return on Capital Employed (ROCE)	2.10%	3.10%	2.50%	1.30%	0.50%	5.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.76%	3.34%	-0.20%	4.19%	-2.96%	2.21%
FCF Yield	1.43%	1.31%	4.70%	3.70%	11.12%	2.71%
Buyback Yield / Dilution	-10.50%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

SEC Filings: 10-K · 10-Q